CPOP Masthead

The following courses are provided for health professionals in Western Australia delivering opioid substitution treatment in the Community Program for Opioid Pharmacotherapy (CPOP).

REGISTRATION and ACCESS to CPOP Courses:

WA pharmacies that require CPOP authorisation should complete an Application for a pharmacy to to participate in CPOP (click link) 

All pharmacists working in CPOP pharmacies (including locums) are required to complete the CPOP Pharmacist Training accessible below

CPOP Depot Pharmacist training is also required for dispensing of these formulations

Medical Practitioners who require authorisation to prescribe opioid substitution treatment in WA must first:

  • Complete an Application to be an Authorised CPOP Prescriber (click to access)
  • Sign the prescriber declaration, and
  • Submit the completed form to the Community Pharmacotherapy Program
      • via email to CPPAdmin@mhc.wa.gov.au or
      • fax to (08) 9471 0444

An access key will be provided on receipt of their application

 

Help with Search courses

CPOP Policies, Procedures and Guidelines

This section contains the current policy and procedure documentation for the Community Program for Opioid Pharmacotherapy

CPOP Pharmacist Online Training

This course is designed for Western Australian Pharmacists and other health professionals dispensing opioid substitution treatment in the form of supervised methadone and buprenorphine doses to CPOP clients.

Depot Buprenorphine Training for Pharmacists participating in CPOP

This course is designed for Western Australian pharmacists and other health professionals who dispense opioid substitution treatment in the form of supervised methadone and buprenorphine doses and who supply depot buprenorphine formulations to medical centres and clinics. 

CPOP Prescriber Depot Buprenorphine Accreditation

This training is for currently authorised prescribers in the WA Community Program for Opioid Pharmacotherapy (CPOP). Upon successful completion of this training and assessment CPOP Prescribers will be recommended for approval to prescribe depot buprenorphine formulations.

Approval as a CPOP Prescriber is issued by Chief Delegate of the Medicines and Poisions Regulation Branch, WA Department of Health and all providers are required to operate in accordance with WA CPOP Policies and Procedures and all associated policies and guidelines.

Sublingual Buprenorphine Administration & Resources

These resources demonstrate the administration and regulatory requirements for approved sublingual buprenorphine formulations. See below for: links to the Australian Product Information and Consumer Medicine Information for comprehensive prescribing and administration requirements.

In Western Australia sublingual buprenorphine is dispensed through authorised pharmacies under the direction of a medical practitioner approved by WA Department of Health to prescribe as part of the Community Program for Opioid Pharmacotherapy (CPOP). Refer to the WA CPOP Policies,Procedures and Guidelines for comprehensive prescribing and dispensing requirements. 

For further clinical information on CPOP contact CPOP Advice and Support (CAS) on  9442 5042.

Depot Buprenorphine: Administration and Resources

These videos and resources demonstrate how to administer the two different CPOP approved depot buprenorphine products and provide links to the Australian Product Information and Consumer Medicine Information.

In Western Australia depot buprenorphine can only be administered by an authorised health professional (i.e. medical practitioner, pharmacist or nurse) under the direction of a health professional (i.e. medical practitioner or nurse practitioner) who has approval from the WA Department of Health to prescribe depot buprenorphine products through the Community Program for Opioid Pharmacotherapy (CPOP). 

For further information on the appropriate administration of depot buprenorphine contact CPOP Advice and Support (CAS) on  9442 5042.